Home
About
Leadership
OUR LEADERSHIP
Executive Committee
The committee steers the network’s growth, governance and capacity-building agenda across the continent.
THE CHAIR
01 of 04
CHAIRMAN
Prof. Collen Masimirembwa
AiBST · Zimbabwe
Founder of the Pan-African DMPK Centre of Excellence at AiBST and a three-decade veteran of drug metabolism and pharmacogenomics across Africa. Chairs the network with a mandate to make African DMPK scientists visible, relevant and indispensable to global drug discovery.
EXECUTIVE COMMITTEE
02–04
VICE CHAIRMAN
Dr. Arnold Forkuo Donkor
KNUST · Ghana
Antimalarial drug discovery
and lead optimisation.
TREASURER
Dr. Janine Scholefield
CSIR · South Africa
Principal scientist.
Research on African plant-derived leads.
SECRETARY
Dr. Roslyn Thelingwani
AiBST · Zimbabwe
CYP variant characterisation;
pharmacogenomic studies.
“
The committee’s job is not to lead the network — it’s to make sure the network can lead itself. Decisions get made closest to the work.
— EXECUTIVE COMMITTEE CHARTER
WORKING GROUPS
Where the day-to-day work happens.
Topic-led working groups translate the network’s strategy into action. Members can join any group; chairs rotate annually.
01
Assay standardisation.
Harmonising Tier 1 and Tier 2 ADME protocols across network labs.
FORMING
02
Training cohorts.
Designing the curriculum and selecting cohorts for workshops and webinars.
FORMING
03
Publications.
Coordinating network publications, joint reviews and conference presentations.
FORMING
04
Industry engagement.
Building pipelines into pharmaceutical sponsors and policy partners.
FORMING